GemVax & KAEL젬백스
082270 · KOSDAQ · ₩082270 · 젬백스
₩8,650▼ ₩400 (4.42%)End-of-day · Oct 30, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 42.5% | 42.8% | 31.4% | 36.1% | 28.8% | 31.3% |
| Operating margin | 10.0% | 4.7% | −61.2% | −10.9% | −5.2% | −6.0% |
| Net margin | −14.4% | −13.9% | −139.1% | −37.6% | −25.9% | 20.0% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +4.4% | +30.1% | −13.2% | −4.7% | +25.6% | — |
| Operating income growth | +123.7% | +109.9% | −387.2% | −99.4% | −8.7% | — |
| Net income growth | −7.9% | +87.0% | −220.9% | −38.6% | −262.6% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | −42.6% | −26.3% | −127.3% | −22.4% | −44.7% | −25.8% |
| Return on assets | −7.6% | −7.3% | −61.0% | −19.0% | −12.1% | 7.0% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 63,761.1% | 177.6% | 419.7% | 25.1% | 12.5% | −39.3% |
| Net debt to equity | 12,247.1% | 27.2% | 127.4% | −6.2% | −7.2% | 28.8% |
| Current ratio | 107.9% | 65.6% | 35.8% | 129.8% | 380.0% | 326.0% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: GemVax & KAEL / 젬백스 / 082270 / KRX:082270
Source: KRX statistical information